Impact of Metabolic Syndrome On Hospital Outcome In Patients With Acute Coronary Syndrome In Hawler Teaching Hospital

Dilshad Abdulkadir  Rasul; Abdulkareem Abdulwahhab  Al-Othman

Authors

Dilshad Abdulkadir Rasul Candidate for Kurdistan Board for Medical Specialization in Internal Medicine M.B.CH.B, Hawler Teaching Hospital- Department of Medicine- Erbil-Iraq
Abdulkareem Abdulwahhab Al-Othman

Keywords:

Acute coronary syndrome, Metabolic syndrome

Abstract

Background and Objectives

According to the world health organization data published on April 2011, coronary heart disease deaths reached 14.12% of the total deaths in Iraq.

The objective of the study was to evaluate the effect of metabolic syndrome on in hospital complications, left ventricular systolic function and ischemic mitral regurgitation in patients with first acute coronary syndrome.

Patients and Methods:

The study sample consisted of 95 patients (57 male, 38 female), their ages ranged between 35-90 years with the first acute coronary syndrome who had been admitted to the Coronary Care Unit of Hawler Teaching Hospital from October 2013 to April 2014.Patients were categorized in to group A that represent those with metabolic syndrome and group B without met- abolic syndrome.

Results:

Hypertension, diabetes, fasting hyperglycemia and hypertriglyceridemia were higher among group A than group B. Cardiogenic shock, pulmonary edema, arrhythmias, mortality, early ischemic mitral regurgitation and early Left ventricular systolic dysfunction were higher among group A vs. group B but without statistical significance.

Conclusions:

Metabolic syndrome is an important predictor for in hospital complications, left ventricular systolic dysfunction and early ischemic mitral regurgitation in patients with acute coronary syndrome.

Downloads

Download data is not yet available.

References

- EcKel RH. The metabolic syndrome. In: Fauci AS,Longo DL, Kasper DL, Hauser S L, J. Jameson l, Loscalzo j (Eds) Harrison’s principles of Internal Medicine.18th edition The McGraw-Hill , 2012. Ch. 242; p.1992-1994.

- Stern MP, Williams K, Gonzalez-Villalpando C, Hunt KJ, Haffner SM. Does the metabolic syndrome improve identifi- cation of individuals at risk of type 2 diabetes and/or cardio- vascular disease? Diabetes Care. 2004; 27:2676-81.

- Shehab A, Al-Dabbagh B, Almahmeed W, Bustani N, Nagelkerke N, Alnaeemi A et al, Prevalence, Characteristics, and In-Hospital Outcomes of Metabolic Syndrome among Patients with Acute Coronary Syndrome in the Unit- ed Arab Emirates, Open Cardiovasc Med J. 2012; 6: 81–87.

- World Life Map, Health profile: Iraq http://www.worldli- feexpectancy.com

- Alberti KG, Zimmet P and Shaw J. The metabolic syndrome

a new worldwide definition. Lancet 2005; 366: 1059-62.

- Thygesen K, Alpert JS, Jaffe AS, Simoons ML,Chaitman BR,White HD. Third universal definition of myocardial in- farction. European Heart Journal .2012;33, 2551–2567.

- Chobanian AV, Bakris GL, Black HR,Cushman WC,Green LA,Izzo JL et al. The JNC 7 Report. JAMA. 2003; 289(19):2560-2571.

- Diagnosing Diabetes and Learning about Pre-diabetes, American Diabetic Association. http://www.diabetes.org. July 31, 2013.

- Hollenberg S. Cardiogenic shock. In: Goldman L and Schafer AI, (eds). Goldman’s Cecil Medicine 24th Edition

.USA.SAUNDERS ELSEVIER.2011.p.654.

- Ramdas G, Pravin MS. Assessment of left ventricular function. Imaging in Cardiovascular Disease.1st edition. Lippincott Williams&?Willkins.2000;p.23-41.

- Enriquez- SM, Schaff HV, Tajik AJ. Chronic mitral Re- gurgitation. In: Alpert JS, Dalen JE, Rahimtoala SH (Eds): Valvular Heart Disease. 3rd ed. Philadelphia. Lippincott Williams and Wilkins.2000; p. 113-142.

- Matsummura T, Ohtaki E, Tanaka K. Echocardiographic predictors of Left ventricular dysfunction after mitral valve repair for mitral regurgitation as an indicator to decide the optimal timing of repair. J Am Cardiol.2003; 42:458.

- Dawson B, Trapp RG.multiple dependent variables, in: Beth Dawson, Robert G. Trapp (Eds) Basic and clinical biostatistics, fourth ed. USA Lange medical books/Mc- Graw-hill.2004;p:184.

- Al Suwaidi J, Zubaid M, El-Menyar AA. Prevalence of the metabolic syndrome in patients with acute coronary syndrome in six Middle Eastern countries. J Clin Hypertens. 2010; 12: 890-9.

- Jover A, Corbella E, Munoz A, Millan J, Pinto X, Man- gas A et al. Prevalence of Metabolic Syndrome and its Com- ponents in Patients with Acute Coronary Syndrome. Rev Esp Cardiol. 2011; 64:579-86.

- Zimmet P, Hodge A, Nicolson M. Serum leptin concen- tration, obesity, and insulin resistance in Western samoas: cross sectional study. BMJ 1996; 13:9659.

- Roemmich JN, ClarkPA, Berr VM, Mantazoros CS, Fli- er JS. Gender differences in leptin levels during puberty are related to the subcutaneous fat depot and sex steroids. Am J Physiol Endocrinol Metab.1998; 275: 543-51.

- Viitasalo A, Lakka T A, Laaksonen D A, Savonen K, Lakka H M, Hassinen M et al, Validation of metabolic syn-

drome score by confirmatory factor analysis in children and adults and prediction of cardiometabolic outcomes in adults. Diabetologia.2014; 125: 3172.

- Zeller M, Steg PG, Ravisy J, Laurent Y, Janin ML, Is- abelle LH, Beer J G. Prevalence and Impact of Metabolic Syndrome on Hospital Outcomes in Acute Myocardial In- farction. Arch Intern Med. 2005;165:1192-1198.

- El-Yassin H D, Al- Sharifi Z A, Al-Jeboori S. A study on the Prevalence of Dyslipidemic Disorder among Resi- dents of Karbala City. The Iraqi Postgraduate Medical Jour- nal.2011;3:358-366.

- Kim JY, Mun HS, Lee BK, Yoon SB, Choi EY, Min PK, et al. Impact of metabolic syndrome and its individual com- ponents on the presence and severity of angiographic coro- nary artery disease. Yonsei Med J. 2010; 51:676–82.

- Ahnve S, Angelin B, Edhag O, Berglund L. Early deter- mination of serum lipids and apolipoproteins in acute myo- cardial infarction: possibility for immediate intervention. J Intern Med. 1989; 226:297–301.

- Henkin Y, Crystal E, Goldberg Y, Friger M, Lorber J, Zuili I et al. Usefulness of lipoprotein changes during acute coronary syndromes for predicting post-discharge lipopro- tein levels. Am J Cardiol. 2002; 89:7–11.

- Lee M G, Jeong M H, Ahn Y, Chae S C, Hur S H, Hong T J et al, Impact of the Metabolic Syndrome on the Clinical Outcome of Patients with Acute ST-Elevation Myocardial Infarction. J Korean Med Sci. 2010; 25: 1456-1461.

- Yazici H.U, Poyraz F, Turfan M, Sen N, Tavil Y, Tulmac M et al, The prevalence of the metabolic syndrome and its impact on the left ventricular systolic function in the patients with non-diabetic first ST elevation myocardial infarction. European Review for Medical and Pharmacological Sci- ence. 2012; 16: 90-95.

- Osman K A, Ahmed M H, Hypothesis Moderate isch- emic mitral regurgitation and metabolic syndrome: where are we now and where are we going? Cardiovascular Dia- betology.2006;5:24.